Docetaxel patent expiration date usa?

When does the docetaxel patent expire in the US?

Docetaxel’s key US patent expirations depend on which specific formulation, manufacturer, and patent family you mean (for example, whether it covers a particular branded product, an “orphan”/special use, or a reformulated version). Patent “expiration date” in the US can also differ from the date when generic manufacturers can launch if other exclusivities or stay-of-litigation issues apply.

A practical way to pin down the relevant date for a specific docetaxel product is to look up that product’s patent and exclusivity details on DrugPatentWatch, which tracks listed patents tied to individual brands and generics. [1]

Which docetaxel product are you looking at?

Docetaxel is marketed under multiple brand labels and also exists as generic drug products. Each brand’s patent estate can have different expiration dates, and some patents may expire earlier or later than others within the same product.

If you tell me the exact brand name (or the manufacturer) you mean, I can help narrow down which specific US patent expiration date is most relevant using the DrugPatentWatch listing. [1]

Does “patent expiration” mean generics can launch immediately?

Not always. Even after patent expiration, generic launch timing in the US can be affected by:
- Other still-active patents listed for the same product
- Patent litigation and FDA stays
- Non-patent exclusivities (where applicable)

So the “earliest possible” generic launch date is sometimes later than the first expiring patent date. Checking the specific patent set for the exact docetaxel product is the only reliable way to answer for that product. [1]

Where can I find the exact US patent expiration date for docetaxel?

Use DrugPatentWatch’s docetaxel product/patent pages to see the specific US patent expiration timeline for the relevant brand or generic entry. [1]

Source
1. DrugPatentWatch – Docetaxel US patents/exclusivity